close

News WrapGet Handpicked Stories from our editors directly to your mailbox

Ranbaxy

ED conducts raids at residences of Ranbaxy group promoters Malvinder, Shivinder Singh

Singh brothers were booked in March on charges of cheating, criminal conspiracy and breach of trust related to Religare Enterprises and its subsidiary Religare Finvest Limited (RFL).

Aug 01, 2019, 14:38 PM IST

We will send you to jail: SC to ex-Ranbaxy promoters

The court was hearing a petition filed by Daiichi Sankyo, which is seeking to recover Rs 3,500 crore awarded to it in an arbitration by a Singapore tribunal against the Ranbaxy brothers.

Apr 05, 2019, 17:05 PM IST

SC asks ex-Ranbaxy promoters to apprise how they'll comply with Rs 3500 cr arbitral award

The bench asked the Singh brothers to appear before it on March 28 and submit the plan.

Mar 14, 2019, 12:03 PM IST

Prices of 56 drugs to come down; NPPA fixes ceiling rates

Prices may come down of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and high blood pressure, with the government fixing their ceiling prices under the drug pricing control mechanism.

Jun 06, 2016, 17:51 PM IST

Sun Pharma withdraws suit filed by Ranbaxy against USFDA

The lawsuit challenged FDA's revocation of Ranbaxy's tentative approvals for its generic versions of Nexium and Valcyte in the US.

Oct 09, 2015, 14:54 PM IST

Strides Arcolab shares up 4% on Sun Pharma deal

Shares of Strides Arcolab rose by 4 percent Monday as it entered into a pact with Sun Pharma to buy from it erstwhile Ranbaxy's two divisions in central nervous system (CNS) segment in India for Rs 165 crore.

 

Sep 21, 2015, 13:27 PM IST

Sun Pharma to sell Ranbaxy's 2 CNS divisions to Strides for Rs 165 crore

Sun Pharmaceutical Industries Ltd is selling erstwhile Ranbaxy's two divisions in central nervous system (CNS) segment in India to Strides Arcolab for Rs 165 crore.

 

Sep 19, 2015, 15:13 PM IST

Nifty tumbles 74 points on frantic selling; pharma stocks tank

The broader 50-share NSE Nifty opened higher at 8,601.50 and fluctuated between a high of 8,646.75 and low of 8,517.90 before ending at 8,529.45, a sharp fall of 74 points, or 0.86 percent.

Jul 21, 2015, 19:46 PM IST

Sun Pharma asks 18 top brass of Ranbaxy to resign

This comes after a year after the Dilip Shanghvi-led firm acquired Ranbaxy in an all-stock deal and the company's Q4 profits shrank 44 per cent due to costs incurred in assimilating the buyout.

Jun 18, 2015, 12:23 PM IST

Focus on getting Ranbaxy's plants USFDA nod one at a time: Sun Pharma

The Mumbai-based drug major, which acquired Ranbaxy in a USD 4 billion deal, feels it is important for the merged entity to "re-establish" the trust between Ranbaxy and the US Food and Drug Administration (USFDA).

Jun 07, 2015, 14:41 PM IST

Daiichi Sankyo exits Sun Pharma; ends 7 years of tumultuous ride in India

The company, which had forayed into the growing Indian pharmaceutical market by buying a majority stake in Ranbaxy Laboratories in 2008 for Rs 22,000 crore, sold over 21 crore shares in Sun Pharma.

Apr 21, 2015, 14:42 PM IST

Sun Pharma shares tank 11% as Daiichi completes exit

Shares of Sun Pharmaceutical on Tuesday plunged nearly 11 percent after Japan's Daiichi Sankyo announced selling its entire holding in the Indian drug major for an estimated Rs 20,420 crore.

Apr 21, 2015, 13:46 PM IST

Sun Pharma slumps most in near six years on Daiichi's share sale

Shares of Sun Pharmaceutical Industries Ltd slumped as much as 10.9 percent on Tuesday, heading towards their biggest daily fall since June 2009 after Japan`s Daiichi Sankyo Co Ltd started selling its stake in the Indian drugmaker.

Apr 21, 2015, 10:15 AM IST

Sensex surges 302 points; logs 1st weekly gain in three weeks

The 50-share NSE Nifty also rose by 95.25 points or 1.12 percent, to 8,586.25 after hitting today's high of 8,603.40.

Apr 01, 2015, 17:14 PM IST

BSE to discontinue trading in Ranbaxy from April 6

The BSE has decided to delist Ranbaxy scrip from S&P BSE 100, S&P BSE 200, S&P BSE 500, S&P BSE Healthcare and S&P BSE Carbonex indices from April 6.

Mar 27, 2015, 21:19 PM IST

Sun Pharma, Ranbaxy rise after regulatory nods for merger deal

At the end of today's trade, Sun Pharmaceutical Industries ended at Rs 1,039.85, up 1.55 percent and Ranbaxy Laboratories closed at Rs 819.55 apiece, up 1.86 percent.

Mar 24, 2015, 17:33 PM IST

Sun Pharma, Ranbaxy rise after regulatory nods for merger deal

Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories today settled in the positive territory after regulatory nods paved the way for completion of their USD 4-billion merger.

Mar 24, 2015, 17:20 PM IST

Sun-Ranbaxy deal gets final CCI nod; Emcure to buy 7 brands

Sun Pharma and Ranbaxy have got approval from the Competition Commission for sale of seven brands to Emcure Pharma to comply with the fair trade watchdog's conditional nod for their USD 4-billion merger.

Mar 23, 2015, 20:08 PM IST

CAG blames I-T Dept for Rs 1348 cr tax loss in pharma sector

Coming down heavily on the I-T Department, CAG has said non-compliance of procedures for giving incentives to pharmaceutical firms, including Ranbaxy, Dr Reddy's and Piramal, resulted Rs 1,348.44 crore loss to the exchequer.

Mar 20, 2015, 19:28 PM IST

Ranbaxy loses approvals, exclusivity of 2 drugs in US

Ranbaxy Laboratories' tentative approvals for its generic versions of digestive disorder drug Nexium and antiviral Valcyte along with 180-days marketing exclusivity stands canceled following a US court decision.

Mar 03, 2015, 16:21 PM IST